Summary: The Centers for Medicare & Medicaid Services modified its granulocyte transfusion coverage policy, effective May 15, 2026. Here's what billing teams need to know before claims go out the door.
CMS granulocyte transfusion coverage policy has been updated — and if your facility bills for blood component therapy, this change belongs on your radar now. The Centers for Medicare & Medicaid Services has modified its policy governing granulocyte transfusions, with an effective date of May 15, 2026. The policy does not carry a numbered policy code in the standard NCD or LCD format. No specific CPT or HCPCS codes are listed in the published policy data — more on what that means for your billing team below.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | CMS (Centers for Medicare & Medicaid Services) |
| Policy | Granulocyte Transfusions |
| Policy Code | N/A |
| Change Type | Modified |
| Effective Date | May 15, 2026 |
| Impact Level | Medium-High |
| Specialties Affected | Hematology, oncology, infectious disease, hospital-based transfusion medicine, inpatient billing |
| Key Action | Audit your granulocyte transfusion billing workflows and confirm medical necessity documentation is in place before May 15, 2026 |
CMS Granulocyte Transfusion Coverage Criteria and Medical Necessity Requirements 2026
Granulocyte transfusions are not everyday billing territory. They're administered to severely neutropenic patients — typically those undergoing chemotherapy or bone marrow transplantation — who have life-threatening infections that haven't responded to antibiotics or antifungals. The clinical bar is high. So is the documentation bar.
CMS coverage of granulocyte transfusions has always hinged on medical necessity. The general framework requires that the patient has severe neutropenia, that a documented infection is present, and that standard antimicrobial therapy has failed or is insufficient. These aren't soft criteria — CMS expects clinical documentation to demonstrate all three elements clearly.
The published policy data for this modification does not include detailed coverage criteria text. That means your billing team needs to pull the full policy directly from the CMS source and confirm which specific criteria were modified. Don't assume the criteria you've been using since the last version still apply without checking.
Prior authorization requirements for granulocyte transfusions vary by Medicare Administrative Contractor. Your MAC may have a local coverage determination that layers on top of the national policy. Check with your MAC before May 15, 2026 — especially if you haven't reviewed your local LCD recently.
The real issue here is documentation. Granulocyte transfusions are expensive, clinically complex, and highly scrutinized. A claim denial in this category often comes down to a documentation gap, not a coverage gap. If your clinical team orders the transfusion but the chart doesn't clearly show failed antimicrobial therapy and severe neutropenia, you're exposed.
Medical necessity documentation for granulocyte transfusions should include absolute neutrophil count (ANC) thresholds, the specific infectious organism if identified, a record of prior antimicrobial treatment and its outcome, and the attending physician's rationale for the transfusion. If your facility doesn't have a documentation template for this, build one before the effective date.
CMS Granulocyte Transfusion Exclusions and Non-Covered Indications
The policy data provided does not list specific exclusions. However, based on CMS's longstanding approach to blood component therapy, certain scenarios have historically not met medical necessity criteria for reimbursement.
Prophylactic granulocyte transfusions — meaning transfusions given to neutropenic patients before an active infection develops — have faced scrutiny under Medicare coverage policy. CMS has generally required that an active, documented infection be present. Prophylactic use without a confirmed infection is a denial risk.
Repeat transfusions without documented clinical response are another exposure point. If the first transfusion shows no improvement and the chart doesn't address why additional transfusions are clinically justified, expect scrutiny. Your billing team should flag cases with multiple transfusion episodes and confirm the documentation supports each one independently.
If you're not sure how the exclusions in the modified policy apply to your patient mix, talk to your compliance officer before May 15, 2026.
Coverage Indications at a Glance
The policy data does not include a structured list of covered and non-covered indications. The table below reflects the established CMS framework for granulocyte transfusion coverage. Verify these against the full policy text at the CMS source before applying them to claims.
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Severe neutropenia with documented, active bacterial or fungal infection unresponsive to antimicrobials | Covered (when medical necessity criteria met) | Not listed in policy data | Full documentation of ANC, infection, and failed therapy required |
| Prophylactic transfusion in neutropenic patient without active infection | Not Covered / High Denial Risk | Not listed in policy data | CMS historically requires active infection; prophylactic use not supported |
| Granulocyte transfusion in non-neutropenic patient | Not Covered | Not listed in policy data | Medical necessity threshold not met without severe neutropenia |
| Repeat transfusions without documented clinical response or ongoing medical necessity | Coverage at Risk | Not listed in policy data | Each transfusion episode requires independent medical necessity documentation |
Verify all indication-level coverage decisions against the full updated policy text effective May 15, 2026.
CMS Granulocyte Transfusion Billing Guidelines and Action Items 2026
Granulocyte transfusion billing is a niche area with real financial exposure. The modification to this coverage policy is your prompt to audit the whole workflow — not just update a fee schedule line item.
| # | Action Item |
|---|---|
| 1 | Pull the full updated policy text from CMS now. The policy data available at publication does not include the modified criteria text. Go to the CMS source directly and read what changed between versions. Don't bill to the old criteria after May 15, 2026. |
| 2 | Contact your Medicare Administrative Contractor before May 15, 2026. Ask whether your MAC has a local coverage determination that intersects with this national policy update. MACs can add criteria, restrict coverage, or require prior authorization beyond what the national policy specifies. Your MAC's position controls your claims. |
| 3 | Audit your medical necessity documentation templates. Pull five to ten recent granulocyte transfusion claims and check whether the charts document ANC at time of transfusion, the specific infection, failed antimicrobial therapy, and physician rationale. If those elements aren't consistently present, fix the template before the effective date. |
| 4 | Flag multi-episode transfusion cases for secondary review. Patients who receive more than one granulocyte transfusion during a single admission are a claim denial risk if each episode isn't independently justified. Build a review step into your workflow for these cases. |
| 5 | Confirm your charge capture matches the codes CMS recognizes. The policy data does not list specific CPT or HCPCS codes. That's a gap you need to close. Work with your coding team to identify the codes your facility currently bills for granulocyte transfusions and confirm CMS reimbursement applies to each one under the updated policy. |
| 6 | Brief your clinical documentation improvement (CDI) team. The CDI team is your first line of defense on medical necessity documentation. They need to know this policy was modified so they can flag charts that don't meet the updated criteria before billing goes out. |
| 7 | If your facility doesn't frequently bill granulocyte transfusions, don't assume you're unaffected. Rare-use procedures are exactly where billing errors hide. A single denied claim for a granulocyte transfusion can be a significant reimbursement hit — these are not low-cost services. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Granulocyte Transfusions Under This Policy
The published policy data for this CMS modification does not list specific CPT, HCPCS, or ICD-10 codes. Do not use codes from other sources as substitutes until you have reviewed the full policy text directly.
What Your Coding Team Should Investigate
Your coding team should identify the specific codes your facility bills for granulocyte transfusions and cross-reference them against the updated CMS policy. Common code categories used for blood component transfusions include HCPCS codes for blood products and transfusion services — but we will not list specific codes here without confirmed policy data.
Billing granulocyte transfusions under the wrong code is a fast path to a claim denial or a recoupment audit. Pull the policy, identify the applicable codes, and document that decision in your coding reference materials.
A Note on Code Availability
When CMS modifies a policy without publishing an associated code list in the accessible policy document, it usually means one of two things. Either the codes are addressed in a separate billing guideline or transmittal, or the modification is criteria-focused rather than code-focused. In either case, the burden is on your team to reconcile the policy with your existing charge capture. Don't wait for someone to tell you the codes changed — check the transmittals and contact your MAC if you're uncertain.
If your compliance officer or billing consultant hasn't reviewed this policy modification yet, get them involved before May 15, 2026. The combination of high-cost services, complex medical necessity criteria, and missing code data in the published policy is exactly the situation where you want a second set of eyes.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.